The Netherlands was hit by COVID-19 in 2020 and the country went into long periods of partial lockdown. In May
Consumer Health in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
123 pages •
By Euromonitor International
• Oct 2020
Consumer health in the UK was positively impacted by the emergence of COVID-19 in Q2 2020 due to notable stockpiling behaviour, a focus on preventive health and consumers adjusting to the new normal. The pandemic and the subsequent lockdown measures introduced by the government in an attempt to halt the spread of the virus resulted in a shift...
123 pages •
By Euromonitor International
• Oct 2020
Consumer health is expected to record higher retail current value growth in 2020 than in the previous year, returning to the growth rates seen in the middle of the review period. This is due to rising interest in health, brought about by the arrival of the COVID-19 pandemic in the country. The higher growth is despite the challenging economic...
111 pages •
By Euromonitor International
• Nov 2020
The fast-spreading COVID-19 virus has dampened economic prospects for 2020. Consumer confidence has been directly hit in Q2 as a result of the first case of COVID-19 being seen at the end of Q1 (11 March), leading to consumers increasingly opting for cheaper Consumer Health brands and generics. Consumer Health in Turkey report offers...
125 pages •
By Euromonitor International
• Dec 2020
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
106 pages •
By Euromonitor International
• Nov 2020
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
103 pages •
By Euromonitor International
• Nov 2020
The Malaysian Government implemented the Movement Control Order (MCO) from 18 March to 4 May in an effort to contain the spread of the COVID-19 pandemic in the country. There followed the Conditional Movement Control Order (CMCO) – between 4 May and 10 June, and the Recovery Movement Control Order (RMCO) – between 10 June and 31 August. All...
101 pages •
By Euromonitor International
• Nov 2020
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
126 pages •
By Euromonitor International
• Nov 2020
The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain...
122 pages •
By Euromonitor International
• Nov 2020
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
111 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see increased current value growth in 2020. The spread of the COVID-19 pandemic has fuelled growth of immunity-boosting vitamins and dietary supplements, as well as topical germicidals/antiseptics in the year. Sleep aids have also benefited from increased levels of stress and anxiety as a result of COVID-19,...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.